This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biontech US Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jaewon Choi: Innovator in T Cell Receptor Constructs
Introduction
Jaewon Choi is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of immunology, particularly in the development of T cell receptor constructs. His work focuses on advancing therapeutic options for various diseases.
Latest Patents
Jaewon Choi holds a patent for T cell receptor constructs and their uses. The patent details T cell receptors (TCRs) that target peptide-MHC complexes, isolated nucleic acid molecules encoding these TCRs, T cells expressing the TCRs, and pharmaceutical compositions aimed at treating diseases. This innovation represents a crucial step in enhancing immune responses against specific targets.
Career Highlights
Choi is currently associated with BioNTech US Inc., where he continues to push the boundaries of research in immunotherapy. His expertise in T cell receptor technology positions him as a key player in the development of novel treatments.
Collaborations
Jaewon Choi collaborates with Vikram Juneja, contributing to the advancement of their shared research goals. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Jaewon Choi's work in T cell receptor constructs showcases his commitment to improving therapeutic strategies in immunology. His contributions are paving the way for future advancements in the treatment of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile